4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001193125-26-004568
General Counsel sold 255 shares at $21.38 ($5,452)
- General Counsel acquired 680 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Winslow Garrett General Counsel | 2026-01-02 | Option exercise | +680 | 2,109 | D | ||
| Winslow Garrett General Counsel | 2026-01-02 | Sale | −255 | $21.38 | $5,452 | 1,854 | D |
| Derivatives | |||||||
| Winslow Garrett General Counsel | 2026-01-02 | Option exercise · Restricted Stock Units | −680 | 1,320 | D | ||
| Open-market sales · 255 sh · avg $21.38 · $5,452 | |||||||
Loading xslF345X05/ownership.xml…